Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis.
about
Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines.Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter.Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.Role of Cytochrome P450 Enzymes in the Metabolic Activation of Tyrosine Kinase Inhibitors
P2860
Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Hepatocellular Toxicity Associ ...... and Inhibition of Glycolysis.
@ast
Hepatocellular Toxicity Associ ...... and Inhibition of Glycolysis.
@en
type
label
Hepatocellular Toxicity Associ ...... and Inhibition of Glycolysis.
@ast
Hepatocellular Toxicity Associ ...... and Inhibition of Glycolysis.
@en
prefLabel
Hepatocellular Toxicity Associ ...... and Inhibition of Glycolysis.
@ast
Hepatocellular Toxicity Associ ...... and Inhibition of Glycolysis.
@en
P2093
P2860
P356
P1476
Hepatocellular Toxicity Associ ...... and Inhibition of Glycolysis.
@en
P2093
Franziska Paech
Jamal Bouitbir
Stephan Krähenbühl
P2860
P356
10.3389/FPHAR.2017.00367
P577
2017-06-14T00:00:00Z